Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+HER2- Breast Cancer × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2750 Neoplasms 2223 Carcinoma, Non-Small-Cell Lung 1670 Prostatic Neoplasms 1496 Colorectal Neoplasms 1217 Lung Neoplasms 1143 Multiple Myeloma 842 Neoplasm Metastasis 817 Leukemia, Myeloid, Acute 788 Pancreatic Neoplasms 763 Ovarian Neoplasms 720 Melanoma 707 Carcinoma, Hepatocellular 659 Recurrence 579 Squamous Cell Carcinoma of Head and Neck 573 Brain Neoplasms 571 Stomach Neoplasms 570 Head and Neck Neoplasms 515 Lymphoma 500 Glioblastoma 499 Uterine Cervical Neoplasms 474 Precursor Cell Lymphoblastic Leukemia-Lymphoma 468 Carcinoma, Renal Cell 451 Triple Negative Breast Neoplasms 444 Endometrial Neoplasms 425 Urinary Bladder Neoplasms 415 Colonic Neoplasms 414 Hematologic Neoplasms 411 Lymphoma, Non-Hodgkin 398 Sarcoma 379

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡